• Carbapenemase Gene Transmission in CREC: Insights from Guang

  2026-07-17

  This study provides a molecular epidemiological analysis of carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae (CREC) from eight teaching hospitals in Guangdong during 2022–2024. Major findings include the predominance and high transferability of plasmid-borne blaNDM-1 and significant multidrug resistance, informing strategies for infection control and antibiotic research.

• Reactive Oxygen Species Assay Kit: Precision for Redox Studi

  2026-07-17

  The Reactive Oxygen Species (ROS) Assay Kit (DHE) empowers researchers to quantify intracellular superoxide with high specificity and reproducibility, fueling advances in oxidative stress and apoptosis research. Its streamlined workflow, robust validation controls, and troubleshooting flexibility set it apart as an essential tool for dissecting redox signaling pathways and cellular oxidative damage.

• AP-2α Downregulates MGMT to Overcome TMZ Resistance in GBM

  2026-07-16

  This study identifies AP-2α as a direct suppressor of MGMT transcription, thereby sensitizing recurrent glioblastoma (GBM) cells to temozolomide (TMZ) by enhancing DNA damage. The findings suggest that modulating MGMT via AP-2α offers a promising strategy to overcome chemotherapy resistance in aggressive brain tumors.

• Transmission Dynamics of Carbapenemase Genes in CREC in Chin

  2026-07-16

  This study characterizes the prevalence, genetic localization, and transmission of carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae (CREC) from eight teaching hospitals in Guangdong, China, during the COVID-19 pandemic. Key findings highlight extensive multidrug resistance and efficient plasmid-mediated gene transfer, underscoring urgent needs for molecular surveillance and robust research tools.

• SGC-CBP30 in Epigenetic Control: Beyond Super-Enhancer Hijac

  2026-07-15

  Explore the advanced utility of SGC-CBP30, a selective CREBBP/EP300 bromodomain inhibitor, for dissecting transcriptional coactivator inhibition in chromatin biology and cancer research. This article uniquely links mechanistic insights from super-enhancer hijacking to practical assay design and translational opportunities.

• Redox-Responsive Peptide Coacervates Advance mRNA Delivery

  2026-07-15

  This study introduces HBpep-SS4, a minimalist redox-responsive peptide coacervate system that enables efficient, cytosol-targeted mRNA delivery. By integrating environmental sensitivity into the peptide backbone, the approach achieves high transfection rates and genome editing efficacy, addressing key limitations of lipid-based nanoparticles and providing a foundation for safer, more controllable mRNA therapeutics.

• Meropenem Trihydrate: Carbapenem Antibiotic for Resistance R

  2026-07-14

  Meropenem trihydrate is a potent carbapenem antibiotic widely used in resistance studies and bacterial infection research. Its broad-spectrum efficacy and low MIC90 values make it a critical benchmark for microbiology and translational research workflows.

• Bardoxolone Methyl: Advanced Redox Modulation for Precision

  2026-07-14

  Explore Bardoxolone methyl as a unique dual modulator of Nrf2 and NF-kB, with new insights into redox regulation, assay design, and translational applications. Distinct from existing content, this article highlights practical implications for oxidative stress research and combinatorial therapy strategies.

• Dlin-MC3-DMA: Advanced Ionizable Cationic Liposome Workflows

  2026-07-13

  Dlin-MC3-DMA empowers reliable and highly potent siRNA and mRNA delivery, enabling breakthroughs in hepatic gene silencing, mRNA vaccine formulation, and immunotherapy research. This article translates the latest data—including machine learning-guided optimization—into stepwise protocols, troubleshooting insights, and comparative advantages for RNA therapeutics.

• BML-277: Chk2 Inhibitor Workflows for DNA Damage Response Re

  2026-07-13

  BML-277, a highly selective Chk2 inhibitor from APExBIO, unlocks precision in DNA damage response and radioprotection assays. This guide translates recent mechanistic insights into actionable protocols, troubleshooting strategies, and advanced use-cases for researchers tackling genome stability and cancer biology.

• Plk1 Regulation of p31comet in Mitotic Checkpoint Disassembl

  2026-07-12

  This study elucidates how Polo-like kinase 1 (Plk1) directly regulates the mitotic checkpoint by phosphorylating p31comet, thereby inhibiting its role in disassembling the mitotic checkpoint complex (MCC). These findings clarify the mechanistic interplay between checkpoint maintenance and silencing, with implications for chromosome segregation fidelity and mitotic progression.

• Cefoperazone (sodium salt): Reliable Antimicrobial Assays, S

  2026-07-10

  This article guides biomedical researchers through real-world laboratory challenges in in vitro antimicrobial and cytotoxicity assays, focusing on reproducibility, β-lactamase resistance, and workflow reliability. Using scenario-driven Q&A and quantitative literature, we demonstrate how Cefoperazone (sodium salt) (SKU C3913) provides robust, data-backed solutions for sensitive and reproducible results.

• Aztreonam’s Dual Role: Gram-Negative Selectivity & Host Cell

  2026-07-09

  Explore the advanced scientific understanding of Aztreonam, a monocyclic β-lactam antibiotic, with new insights into its unique host interactions and resistance implications. This article offers a differentiated perspective for researchers confronting multidrug resistance and assay design challenges.

• Carbapenemase Gene Transmission in Enterobacter cloacae: Ins

  2026-07-09

  This study investigates the genetic mechanisms and epidemiology of carbapenemase-encoding genes in carbapenem-resistant Enterobacter cloacae from eight hospitals in Guangdong, China. The findings highlight the dominance of blaNDM−1, the high prevalence of multidrug resistance, and the efficient horizontal transfer of resistance genes, providing critical context for antibiotic resistance research and modeling.

• SHC-1 Inhibition Regulates CFTR Surface Abundance in Epithel

  2026-07-08

  This study delineates how SHC-1 inhibitors modulate plasma membrane CFTR channel abundance across distinct epithelial cell models. By defining the MAPK/SHC-1 pathway as a conserved regulator of CFTR internalization, the research refines our understanding of post-translational CFTR regulation in disease-relevant contexts and highlights model-specific nuances critical for cystic fibrosis and secretory diarrhea research.

15295 records 1/1020 page Next 12345 下5页 Last page